skip to content
Home

EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers

 

News Subscribe to News

Read more at: Experts call for changes to mesothelioma treatment trials

Experts call for changes to mesothelioma treatment trials

25 September 2025

“Sadly, the UK is the world leader for mesothelioma because we used too much asbestos and banned it far too late. Incidence is probably peaking now in the UK but we will continue to see cases for another generation” Professor Stefan Marciniak, University of Cambridge Trials involving intra-pleural (IP) anti-cancer therapy...

Read more at: New MOF research primer shares lessons learned from IRC

New MOF research primer shares lessons learned from IRC

22 September 2024

“This kind of guide or primer is really useful for researchers entering this rapidly expanding field. We wrote the primer to help them navigate the field, understand potential pitfalls and set out our view of best practice” Professor Ross Forgan of the University of Glasgow IRC members Professor Ross Forgan of the...

Read more at: All-IRC meeting looks to the future

All-IRC meeting looks to the future

8 November 2023

moller-institute-300x300.jpg Thirty members of the IRC, including postdoctoral researchers, academics and clinicians, came together in Cambridge on 21 September 2023 to share progress and map out milestones for the remaining 12 months of this ambitious programme. Opening the meeting, Professor George Malliaras, IRC...

Read more at: MPs demand reform to brain tumour research funding
Cover of APPGBT report

MPs demand reform to brain tumour research funding

4 September 2023

The All-Party Parliamentary Group on Brain Tumours (APPGBT) says wide-ranging changes are needed in how brain tumour research is funded because the current funding system is “unfit for purpose”. The call comes in a new report " Pathway to a cure – breaking down the barriers" based on an inquiry held by the APPGBT which...

Read more at: IRC announces new partnership with the University of Leeds

IRC announces new partnership with the University of Leeds

7 August 2023

head_shot_surgeon_2.jpeg The IRC has announced a new partnership with Ryan Mathew and Heiko Wurdak of the University of Leeds. The new partnership will focus on the translation of local therapeutic drug delivery technologies to treat brain cancer. The partnership, established in April 2023, combines Mathew and Wurdak’s...

Read more at: Read this month’s Cancer in Sight blog:  Living with pancreatic cancer – a patient’s perspective

Read this month’s Cancer in Sight blog:  Living with pancreatic cancer – a patient’s perspective

30 November 2022

This month’s Cancer in Sight blogs is by Sally, a patient and public involvement (PPI) member of the Cambridge Pancreatic Cancer Centre who was diagnosed with pancreatic cancer in 2011 . The Cancer in Sight series of blogs brings a range of perspectives to discuss issues around the IRC’s programme to develop new...

Read more at: IRC Investigator secures Medical Research Council (MRC) Confidence in Concept Award

IRC Investigator secures Medical Research Council (MRC) Confidence in Concept Award

10 November 2022

Professor Oren Scherman has received an MRC Confidence in Concept (CiC) award aimed at acceleration of the translational pathway of a promising invention. The CiC award has been granted to Prof Scherman, Director of the Melville Laboratory and Professor of Supramolecular and Polymer Chemistry in the Yusuf Hamied Department...

Read more at: IRC team at Meet the Researchers public event

IRC team at Meet the Researchers public event

4 November 2022

Members of the IRC team took part in a June Hancock Mesothelioma Research Fund Meet the Researchers event that brought together mesothelioma patients and their families with IRC researchers and clinicians. Meet the Researchers events are an opportunity for researchers and academics to engage with patients and practitioners...

Read more at: Read this month’s Cancer in Sight blog –  Targeted delivery: taking a multidisciplinary approach towards a shared goal

Read this month’s Cancer in Sight blog –  Targeted delivery: taking a multidisciplinary approach towards a shared goal

31 October 2022

The latest in our monthly series of Cancer in Sight blogs is by IRC Programme Manager Claire McGlynn who considers the benefits of bringing together a multidisciplinary team and future prospects for the programme This month’s blog titled ‘ Targeted delivery – taking a multidisciplinary approach towards a shared goal’...

Read more at: Read latest Cancer in Sight blog on the future promise of MOFs

Read latest Cancer in Sight blog on the future promise of MOFs

6 October 2022

The just-published Cancer in Sight blog, written by Professor David Fairén-Jiménez, lead of the Adsorption and Advanced Materials Lab at the University of Cambridge and IRC Investigator, sets out the future promise of MOFs to target hard-to-treat cancers. Explaining how his research is positioned in the wider IRC programme...

Contact Us

For more information on the EPSRC IRC in targeted delivery for hard-to-treat cancers, please contact the Programme Manager, Claire McGlynn

manager@targeted-delivery.cam.ac.uk

Study at Cambridge

About the University

Research at Cambridge